ES2043535B1 - Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona. - Google Patents

Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.

Info

Publication number
ES2043535B1
ES2043535B1 ES09200552A ES9200552A ES2043535B1 ES 2043535 B1 ES2043535 B1 ES 2043535B1 ES 09200552 A ES09200552 A ES 09200552A ES 9200552 A ES9200552 A ES 9200552A ES 2043535 B1 ES2043535 B1 ES 2043535B1
Authority
ES
Spain
Prior art keywords
methyl
carbazol
ona
imidazol
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09200552A
Other languages
English (en)
Spanish (es)
Other versions
ES2043535A1 (es
Inventor
Clotet Juan Huguet
Ges Jose Maria Caldero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Pharma Iberia SL
Original Assignee
Vita Invest SA
Quimica Sintetica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA, Quimica Sintetica SA filed Critical Vita Invest SA
Priority to ES09200552A priority Critical patent/ES2043535B1/es
Priority to SK169-93A priority patent/SK278786B6/sk
Priority to GR930100094A priority patent/GR930100094A/el
Priority to CZ93396A priority patent/CZ281753B6/cs
Priority to EG14493A priority patent/EG20262A/xx
Priority to PT101216A priority patent/PT101216B/pt
Priority to NO930887A priority patent/NO300973B1/no
Priority to IS3985A priority patent/IS1783B/is
Priority to KR1019930003609A priority patent/KR100277414B1/ko
Priority to AR93324474A priority patent/AR248019A1/es
Priority to FI931104A priority patent/FI105098B/fi
Priority to RU93004833/04A priority patent/RU2109741C1/ru
Priority to HU9300718A priority patent/HU210775B/hu
Priority to AT0048793A priority patent/AT402730B/de
Priority to PL93298037A priority patent/PL170751B1/pl
Publication of ES2043535A1 publication Critical patent/ES2043535A1/es
Application granted granted Critical
Publication of ES2043535B1 publication Critical patent/ES2043535B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES09200552A 1992-03-13 1992-03-13 Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona. Expired - Fee Related ES2043535B1 (es)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ES09200552A ES2043535B1 (es) 1992-03-13 1992-03-13 Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
SK169-93A SK278786B6 (sk) 1992-03-13 1993-03-08 Spôsob výroby 1,2,3,9-tetrahydro-9-metyl-3-[(2-met
GR930100094A GR930100094A (el) 1992-03-13 1993-03-09 Μέ?οδος παρασκευής 1,2,3,9-τετραυδρό-9-με?υλό-3-[(2-με?υλό-1Η-ιμιδαζολ-1-υλο)με?υλό]-4Η-καρβαζολ-4-όνης.
EG14493A EG20262A (en) 1992-03-13 1993-03-10 A process for preparing 1,2,3,9- tetrahydro -9- methyl -3-( 2- metyl -1H-imidazol -1- YL) methyl) -4H- carbazol -4- one
CZ93396A CZ281753B6 (cs) 1992-03-13 1993-03-10 Způsob výroby 1,2,3,9-tetrahydro-9-methyl-3-/(2 methyl-1H-imidazol-1-yl)-methyl/-4H-karbazol-4 onu
AR93324474A AR248019A1 (es) 1992-03-13 1993-03-11 Procedimiento para la obtencion de la 1, 2, 3, 9-tetrahidro-9-metil-3-((2-metil-1h-imidazol-1-il)metil)-4h-carbazol-4-on a.
IS3985A IS1783B (is) 1992-03-13 1993-03-11 Aðferð við framleiðslu á 1,2,3,9-tetrahýdró-9-metýl-3-[(2-metýl-1H-imídazól-1-ýl)metýl]-4H-karbasól-4-ón
KR1019930003609A KR100277414B1 (ko) 1992-03-13 1993-03-11 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1h-이미다졸-1-일)메틸]-4h-카바졸-4-온의 제조방법
PT101216A PT101216B (pt) 1992-03-13 1993-03-11 Processo para a preparacao de 1,2,3,9-tetra-hidro-9-metil-3-{(2-metil-1h-imidazol-1-il)metil}-4h-carbazol-4-onas
NO930887A NO300973B1 (no) 1992-03-13 1993-03-11 Fremgangsmåte til fremstilling av 1,2,3,9-tetrahydro-9-metyl-3-£(2-metyl-1H-imidazol-1-yl)metyl|-4H-karbazol-4-on
RU93004833/04A RU2109741C1 (ru) 1992-03-13 1993-03-12 Способ получения 1,2,3,9-тетрагидро-9-метил-3-[(2-метил-1н-имидазол-1-ил)-метил]-4н-карбазол-4-она
HU9300718A HU210775B (en) 1992-03-13 1993-03-12 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl-4h-carbazol-4-one
AT0048793A AT402730B (de) 1992-03-13 1993-03-12 Verfahren zur herstellung von 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol-4-on
PL93298037A PL170751B1 (pl) 1992-03-13 1993-03-12 4H-karbazolonu-4 PL
FI931104A FI105098B (fi) 1992-03-13 1993-03-12 Menetelmä 1,2,3,9-tetrahydro-9-metyyli-[(2-metyyli-1H-imidatsol-1-yyli)metyyli]-4H-karbatsol-4-onin valmistamiseksi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09200552A ES2043535B1 (es) 1992-03-13 1992-03-13 Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.

Publications (2)

Publication Number Publication Date
ES2043535A1 ES2043535A1 (es) 1993-12-16
ES2043535B1 true ES2043535B1 (es) 1994-08-01

Family

ID=8276385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09200552A Expired - Fee Related ES2043535B1 (es) 1992-03-13 1992-03-13 Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.

Country Status (15)

Country Link
KR (1) KR100277414B1 (pl)
AR (1) AR248019A1 (pl)
AT (1) AT402730B (pl)
CZ (1) CZ281753B6 (pl)
EG (1) EG20262A (pl)
ES (1) ES2043535B1 (pl)
FI (1) FI105098B (pl)
GR (1) GR930100094A (pl)
HU (1) HU210775B (pl)
IS (1) IS1783B (pl)
NO (1) NO300973B1 (pl)
PL (1) PL170751B1 (pl)
PT (1) PT101216B (pl)
RU (1) RU2109741C1 (pl)
SK (1) SK278786B6 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100368895B1 (ko) * 2000-03-30 2003-01-24 하나제약 주식회사 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1ｈ-이미다졸-1-일)메틸]-4ｈ-카바졸-4-온의 제조방법
RU2207340C2 (ru) * 2001-08-10 2003-06-27 Ципла Лтд. Способ получения 1,2,3,9-тетрагидро-9-метил-3-[(2-метил-1н-имидазол-1-ил)метил]-4н-карбазол -4-она или его фармацевтически приемлемых солей

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU88268I2 (pl) * 1984-01-25 1994-02-03
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518741D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8617994D0 (en) * 1986-07-23 1986-08-28 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
NO930887L (no) 1993-09-14
HU210775B (en) 1995-07-28
PL170751B1 (pl) 1997-01-31
FI931104A0 (fi) 1993-03-12
GR930100094A (el) 1993-11-30
NO300973B1 (no) 1997-08-25
AT402730B (de) 1997-08-25
RU2109741C1 (ru) 1998-04-27
IS1783B (is) 2001-10-22
IS3985A (is) 1993-09-14
HUT64537A (en) 1994-01-28
PL298037A1 (en) 1993-12-27
SK278786B6 (sk) 1998-02-04
PT101216B (pt) 1999-10-29
EG20262A (en) 1998-05-31
AR248019A1 (es) 1995-05-31
PT101216A (pt) 1994-03-31
ES2043535A1 (es) 1993-12-16
FI931104L (fi) 1993-09-14
FI105098B (fi) 2000-06-15
HU9300718D0 (en) 1993-05-28
KR100277414B1 (ko) 2001-01-15
KR930019665A (ko) 1993-10-18
CZ39693A3 (en) 1994-01-19
CZ281753B6 (cs) 1997-01-15
ATA48793A (de) 1996-12-15
SK16993A3 (en) 1993-11-10
NO930887D0 (no) 1993-03-11

Similar Documents

Publication Publication Date Title
DE50211793D1 (pl)
ATE190799T1 (de) Holzkonservierungsformulierung, die einen komplex aus kupferkation und alkoxyliertem diamin enthält
SV1995000062A (es) DERIVADOS DE CICLOALCANO-INDOL Y - AZAINDOL REF. Le A 30 699
AR006463A1 (es) Composicion de magnesio, titanio, halogeno y ester de acido carboxilico; proceso para su preparacion, uso de la misma como un catalizador, componentecatalizador o en la preparacion de un catalizador, producto o producto intermedio de polimerizacion catalizado por la composicion o preparado por
ES2101994T3 (es) Antioxidantes liquidos como estabilizadores.
CY1116845T1 (el) S-φθορομεθυλεστερας του 6.αλφα.,9.αλφα.-διφθορο-17.αλφα.-[(2-φουρανυλοκαρβονυλ)οξυ]-11.βητα.-υδροξυ-16.αλφα.-μεθυλ-3-οξο-ανδροστ-1,4,-διενο-17-καρβοθειοϊκου οξεος ως ενας αντι-φλεγμονωδης παραγοντας
ES8201948A1 (es) Un procedimiento para la preparacion de nuevos derivados transisomericos de 4-fenil-1,2,3,4- tetrahidro-1-naftalenamina.
ES2146268T3 (es) Procedimiento para la fabricacion de acido amidoetercarboxilico o de una sal del mismo y de una mezcla de agentes con actividad superficial que los contienen.
ES2051715T3 (es) Agentes espesantes.
ES2130472T3 (es) Guanididas de acidos alquenilcarboxilicos sustituidas con fenilo, portadoras de grupos perfluoroalquilo, procedimiento para su preparacion, su uso como medicamento o agente diagnostico, asi como medicamento que las contiene.
FI911512A0 (fi) Oeverbasiska calixarater, foerfarande foer deras framstaellning, kompositioner innehaollande desamma och deras anvaendning som tillsatsaemnen i smoerjaemnen.
ES2043535B1 (es) Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
PE6297A1 (es) Un metodo de identificar un producto de petroleo que contiene un marcador de base reactiva
JPS6413041A (en) Agent for suppressing growth of polymer in olefin-production apparatus
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
ES2155621T3 (es) Derivados azo del acido 5-aminosalicilico para el tratamiento de la enfermedad inflamatoria intestinal.
ES2023455B3 (es) Composicion endurecible sobre la base de un producto de adicion-michael procedimiento para su obtencion asi como su aplicacion.
NO910957L (no) Fluorbenzensulfonamider, fremgangsmaate for fremstilling derav, samt preparat som inneholder slike forbindelser.
ES2196069T3 (es) Derivados morfinoides condensados con heterociclos.
ES2064983T3 (es) Dispositivo para el tratamiento termico y/o humectacion de carretes, canillas y conos.
ES2079464T3 (es) Derivados dipeptidicos de muramilo.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.
ES2123827T3 (es) Derivados del acido poliamidico con actividad antigastrina, un metodo para su preparacion y su uso farmaceutico.
IT1113373B (it) Derivati del 1,5-dimetilbiciclo(3.2.1.)-ottano,preparazione di questi composti e loro impiego come composti per profumi
GB1552166A (en) Polycyclic scents

Legal Events

Date Code Title Description
GC2A Exploitation certificate registered application with search report

Effective date: 19980113

PC2A Transfer of patent
GC2A Exploitation certificate registered application with search report

Effective date: 20030305

PC2A Transfer of patent
PC2A Transfer of patent
PC2A Transfer of patent

Owner name: WARNER CHILCOTT IBERIA, S.L.

Effective date: 20120411

FD2A Announcement of lapse in spain

Effective date: 20141120